{"id":"saline-0-9-matching-placebo","safety":{"commonSideEffects":[{"rate":null,"effect":"No expected adverse events (inert placebo)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Normal saline (0.9% NaCl) matches the osmolarity of human blood plasma (~308 mOsm/L) and is used as a standard placebo control in clinical trials because it has no pharmacological activity. It maintains fluid balance and electrolyte homeostasis without therapeutic effect, making it an ideal inert comparator for blinded studies.","oneSentence":"Saline 0.9% is an isotonic sodium chloride solution that serves as a physiologically inert vehicle for drug delivery or fluid replacement.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:06:38.990Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Placebo control in clinical trials"}]},"trialDetails":[{"nctId":"NCT07037771","phase":"PHASE3","title":"A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-06-17","conditions":"Homozygous Familial Hypercholesterolemia","enrollment":60},{"nctId":"NCT06033196","phase":"PHASE2","title":"Tocilizumab in Lung Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-02-13","conditions":"Lung Transplant","enrollment":350},{"nctId":"NCT06209177","phase":"PHASE1","title":"Study of ARO-CFB in Adult Healthy Volunteers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2024-04-05","conditions":"IgA Nephropathy","enrollment":49},{"nctId":"NCT05992935","phase":"PHASE1, PHASE2","title":"Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-08-25","conditions":"Norovirus Acute Gastroenteritis","enrollment":1405},{"nctId":"NCT07207954","phase":"PHASE1","title":"Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis","status":"RECRUITING","sponsor":"Lifordi Immunotherapeutics, Inc.","startDate":"2025-10-06","conditions":"Rheumatoid Arthritis","enrollment":176},{"nctId":"NCT06229483","phase":"PHASE3","title":"The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies","status":"RECRUITING","sponsor":"Stephen Lownie","startDate":"2024-04-03","conditions":"Brain Tumor, Bleeding","enrollment":102},{"nctId":"NCT07227948","phase":"PHASE2","title":"Repurposing Semaglutide for the Treatment of Cocaine Use Disorder","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2026-01-15","conditions":"Cocaine Use Disorder","enrollment":75},{"nctId":"NCT06226805","phase":"PHASE2","title":"Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)","status":"RECRUITING","sponsor":"Basking Biosciences, Inc.","startDate":"2024-07-31","conditions":"Acute Ischemic Stroke","enrollment":228},{"nctId":"NCT07474909","phase":"NA","title":"Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery","status":"NOT_YET_RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-04-01","conditions":"Hand Injuries and Disorders, Wrist Sprain","enrollment":150},{"nctId":"NCT07327931","phase":"NA","title":"PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-02-13","conditions":"Hip Osteoarthritis, Hip Pain Chronic","enrollment":120},{"nctId":"NCT07474077","phase":"PHASE3","title":"Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH","status":"NOT_YET_RECRUITING","sponsor":"Sultan Qaboos University","startDate":"2026-05-01","conditions":"Post Partum Haemorrhage","enrollment":88},{"nctId":"NCT05683457","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Allogenic Hematopoietic Cell Transplantation (HCT) Participants.","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-04-05","conditions":"Cytomegalovirus Infection","enrollment":224},{"nctId":"NCT07452146","phase":"PHASE2","title":"Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2026-06","conditions":"Alcohol Use Disorder, Inflammatory Response, Craving","enrollment":64},{"nctId":"NCT07463339","phase":"PHASE2","title":"Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2026-05-01","conditions":"Critical Illness, Mechanical Ventilation","enrollment":70},{"nctId":"NCT06901531","phase":"PHASE3","title":"A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer","status":"RECRUITING","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2025-05-22","conditions":"Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer","enrollment":500},{"nctId":"NCT07465198","phase":"PHASE2","title":"Autologous Stem Cell Therapy in Patients With Multiple System Atrophy","status":"NOT_YET_RECRUITING","sponsor":"Biocells Medical","startDate":"2026-09-01","conditions":"MSA - Multiple System Atrophy, MSA","enrollment":50},{"nctId":"NCT07456670","phase":"PHASE2","title":"Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support","status":"NOT_YET_RECRUITING","sponsor":"Queen's University","startDate":"2026-04-01","conditions":"Preterm Birth, Caffeine, Neonatal Outcomes","enrollment":62},{"nctId":"NCT07333859","phase":"PHASE4","title":"Effect of IV Lidocaine on Duodenal Peristalsis and Sedation in ERCP","status":"RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-02-11","conditions":"Duodenal Spasm, ERCP, Sedation","enrollment":120},{"nctId":"NCT06680479","phase":"PHASE1","title":"Safety and Immunogenicity of Stabilized CH505 TF chTrimer Vaccination in Adults Living With HIV-1 on Suppressive Antiretroviral Therapy","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-01","conditions":"HIV-1","enrollment":30},{"nctId":"NCT07434310","phase":"PHASE3","title":"Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults","status":"NOT_YET_RECRUITING","sponsor":"Dr. Naveed Siddiqui","startDate":"2026-05-01","conditions":"Bowel Diseases, Inflammatory, Bowel Surgery, Laparoscopic Abdominal Surgeries","enrollment":70},{"nctId":"NCT06592794","phase":"PHASE3","title":"A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2024-09-24","conditions":"Acute Gastroenteritis, Norovirus Acute Gastroenteritis","enrollment":37864},{"nctId":"NCT04998201","phase":"PHASE2","title":"Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2021-09-28","conditions":"Mixed Dyslipidemia","enrollment":353},{"nctId":"NCT05174507","phase":"PHASE2","title":"Empagliflozin and Anakinra for the Treatment of Postprandial Hypoglycemia in Patients With Prediabetes","status":"WITHDRAWN","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-06-24","conditions":"Postprandial Hypoglycemia","enrollment":""},{"nctId":"NCT06994442","phase":"PHASE3","title":"Optimizing Pain Treatment in Children On Mechanical Ventilation","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2025-12-29","conditions":"Mechanical Ventilation, Pediatric Acute Respiratory Failure, Analgesics, Opioid","enrollment":644},{"nctId":"NCT03929601","phase":"PHASE2","title":"Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2023-10-30","conditions":"Type 1 Diabetes Mellitus","enrollment":74},{"nctId":"NCT03295383","phase":"PHASE3","title":"Randomized Clinical Trial Comparing the Safety and Efficacy of Rituximab Versus Oral Cyclophosphamide in Severe Forms of Mucous Membrane Pemphigoid","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2019-07-11","conditions":"Severe Forms of Mucous Membrane Pemphigoid","enrollment":130},{"nctId":"NCT05160506","phase":"PHASE2","title":"Corticosteroids to Treat Pancreatitis","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2022-03-06","conditions":"Pancreatitis, Pancreatitis, Acute, Corticosteroid","enrollment":86},{"nctId":"NCT07167693","phase":"PHASE1, PHASE2","title":"Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes","status":"RECRUITING","sponsor":"David K Carroll","startDate":"2025-12-19","conditions":"Diabetes (DM), Diabetic Ketoacidosis, Ketosis Prone Diabetes","enrollment":60},{"nctId":"NCT07404358","phase":"PHASE3","title":"Dalargin for Prevention of Organ Disfunction in High-Risk Abdominal Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Botkin Hospital","startDate":"2025-05-13","conditions":"Postoperative Complications, Multiple Organ Failure, Abdominal Surgery","enrollment":200},{"nctId":"NCT07398612","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-01-31","conditions":"Acute Ischemic Stroke","enrollment":60},{"nctId":"NCT06501586","phase":"PHASE1","title":"Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects","status":"COMPLETED","sponsor":"Suzhou Sanegene Bio Inc.","startDate":"2024-07-31","conditions":"Hypertension,Essential","enrollment":40},{"nctId":"NCT02743455","phase":"PHASE1","title":"A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-07-05","conditions":"Yellow Fever, Yellow Fever Immunisation","enrollment":92},{"nctId":"NCT06880770","phase":"PHASE3","title":"Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-04-24","conditions":"Severe Hypertriglyceridemia","enrollment":288},{"nctId":"NCT06143046","phase":"PHASE2","title":"A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-11-15","conditions":"Respiratory Syncytial Virus","enrollment":360},{"nctId":"NCT05089084","phase":"PHASE3","title":"Study of ARO-APOC3 (Plozasiran) in Adults With Familial Chylomicronemia Syndrome (FCS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2021-12-14","conditions":"Familial Chylomicronemia","enrollment":75},{"nctId":"NCT04157348","phase":"PHASE3","title":"Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2019-10-29","conditions":"Eosinophilic Granulomatous Vasculitis","enrollment":140},{"nctId":"NCT05324358","phase":"PHASE3","title":"Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Neumentum, Inc.","startDate":"2022-12-14","conditions":"Pain, Postoperative","enrollment":341},{"nctId":"NCT07353749","phase":"PHASE4","title":"Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms","status":"NOT_YET_RECRUITING","sponsor":"Duan Chuanzhi","startDate":"2026-01-30","conditions":"Unruptured Intracranial Aneurysms, Cerebrovascular Event, Hemorrhagic Stroke","enrollment":864},{"nctId":"NCT07343323","phase":"PHASE1","title":"A First-in-Human Study of KINE-101 in Healthy Volunteers","status":"COMPLETED","sponsor":"Kine Sciences Co., Ltd.","startDate":"2021-11-05","conditions":"Healthy Volunteers","enrollment":40},{"nctId":"NCT05845398","phase":"PHASE1","title":"Phase 1b Study of DCR-AUD in Healthy Volunteers","status":"COMPLETED","sponsor":"Dicerna Pharmaceuticals, Inc., a Novo Nordisk company","startDate":"2023-01-29","conditions":"Alcohol Use Disorder","enrollment":16},{"nctId":"NCT04093219","phase":"PHASE3","title":"PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2020-08-11","conditions":"Delirium in Old Age, Delirium, Coronary Artery Disease","enrollment":900},{"nctId":"NCT04153149","phase":"PHASE3","title":"HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alnylam Pharmaceuticals","startDate":"2019-11-26","conditions":"Transthyretin Amyloidosis (ATTR) With Cardiomyopathy","enrollment":655},{"nctId":"NCT02797522","phase":"PHASE1","title":"A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)","status":"TERMINATED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2016-06","conditions":"Hepatitis B","enrollment":47},{"nctId":"NCT03997383","phase":"PHASE3","title":"APOLLO-B: A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alnylam Pharmaceuticals","startDate":"2019-09-12","conditions":"Transthyretin Amyloidosis (ATTR) With Cardiomyopathy","enrollment":360},{"nctId":"NCT07223658","phase":"PHASE1, PHASE2","title":"Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-12-22","conditions":"Hyperlipidemia; Mixed","enrollment":78},{"nctId":"NCT07324850","phase":"PHASE1","title":"A Study of SGB-7342 in Subjects With Obesity or Overweight","status":"NOT_YET_RECRUITING","sponsor":"Suzhou Sanegene Bio Inc.","startDate":"2026-01-12","conditions":"Obesity & Overweight","enrollment":45},{"nctId":"NCT03783377","phase":"PHASE1","title":"Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2019-03-08","conditions":"Hypertriglyceridemia, Familial Chylomicronemia","enrollment":112},{"nctId":"NCT03747224","phase":"PHASE1","title":"Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2019-01-07","conditions":"Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia","enrollment":93},{"nctId":"NCT03362242","phase":"PHASE1","title":"Study of ARO-AAT in Normal Adult Volunteers","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2018-03-12","conditions":"Alpha 1-Antitrypsin Deficiency","enrollment":45},{"nctId":"NCT06000410","phase":"PHASE3","title":"A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Organogenesis","startDate":"2023-09-06","conditions":"Knee Osteoarthritis","enrollment":594},{"nctId":"NCT07290751","phase":"PHASE4","title":"Intravenous Thrombolysis Combined With Tirofiban in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-11-11","conditions":"Acute Ischemic Stroke","enrollment":976},{"nctId":"NCT06709612","phase":"PHASE2","title":"Postsurgical Analgesia After Hernia Repair","status":"WITHDRAWN","sponsor":"AmacaThera Inc.","startDate":"2025-01-27","conditions":"Hernia Repair, Hernia Inguinal, Hernia Surgery","enrollment":""},{"nctId":"NCT05083364","phase":"PHASE1, PHASE2","title":"Study of ARO-C3 in Adult Healthy Volunteers and Patients With Complement Mediated Renal Disease","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2022-02-01","conditions":"C3 Glomerulopathy, IgA Nephropathy","enrollment":62},{"nctId":"NCT06937203","phase":"PHASE1, PHASE2","title":"Study of ARO-ALK7 in Adult Volunteers With Obesity With and Without Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-05-07","conditions":"Obesity, Diabetes Mellitus, Type 2","enrollment":126},{"nctId":"NCT07277153","phase":"PHASE4","title":"Clinical Study on the Effect of Tegileridine on Postoperative Pain in Patients Undergoing Abdominal Surgery.","status":"COMPLETED","sponsor":"Xin Chen","startDate":"2025-10-18","conditions":"Laparoscopic Surgery for Cholecystitis","enrollment":150},{"nctId":"NCT05085366","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age","status":"TERMINATED","sponsor":"ModernaTX, Inc.","startDate":"2021-10-26","conditions":"Cytomegalovirus Infection","enrollment":7454},{"nctId":"NCT07221344","phase":"PHASE1, PHASE2","title":"Study of ARO-MAPT-SC in Healthy Subjects and Subjects With Early Alzheimer's Disease","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-11-18","conditions":"Alzheimer Disease, Alzheimer Disease, Early Onset","enrollment":112},{"nctId":"NCT04832971","phase":"PHASE2","title":"Study of ARO-ANG3 in Adults With Mixed Dyslipidemia","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2021-06-28","conditions":"Mixed Dyslipidemia","enrollment":204},{"nctId":"NCT07073846","phase":"PHASE4","title":"Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-10-06","conditions":"Morbid Obesity Requiring Bariatric Surgery, Postoperative Pain, Postoperative Pain Management","enrollment":104},{"nctId":"NCT06911944","phase":"PHASE4","title":"Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation","status":"NOT_YET_RECRUITING","sponsor":"Michael Rafii, MD, PhD","startDate":"2026-08-01","conditions":"Down Syndrome (DS), Down Syndrome (Trisomy 21), Alzheimer Disease","enrollment":60},{"nctId":"NCT05743881","phase":"PHASE1","title":"A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-02-15","conditions":"Respiratory Syncytial Virus, Human Metapneumovirus","enrollment":186},{"nctId":"NCT07241546","phase":"PHASE2","title":"Study of Inhaled ARO-RAGE in Allergen-induced Mild Asthma","status":"NOT_YET_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-12","conditions":"Asthma","enrollment":36},{"nctId":"NCT07239115","phase":"PHASE3","title":"Levetiracetam for Seizure Prevention After Brain Tumor Surgery","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-01","conditions":"Postoperative Seizures After Brain Tumor Surgery","enrollment":558},{"nctId":"NCT07238972","phase":"PHASE4","title":"Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2025-12","conditions":"Anemia, Iron Deficiencies, Iron Deficiency Anemia","enrollment":180},{"nctId":"NCT07000877","phase":"PHASE4","title":"Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia.","status":"RECRUITING","sponsor":"Telethon Kids Institute","startDate":"2025-06-25","conditions":"Perioperative Respiratory Adverse Events, Anesthesia Outcomes","enrollment":200},{"nctId":"NCT07079761","phase":"PHASE2","title":"Facilitation of Extinction Retention and Reconsolidation Blockade by IV Allopregnanolone in PTSD.","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-08-04","conditions":"Post Traumatic Stress Disorder","enrollment":96},{"nctId":"NCT03945292","phase":"PHASE2","title":"Safety, Tolerability and Pharmacodynamic Effect of Fazirsiran (TAK-999, ARO-AAT)","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2019-08-07","conditions":"Alpha 1-Antitrypsin Deficiency","enrollment":40},{"nctId":"NCT05684692","phase":"PHASE2","title":"Screening Trial for Pain Relief in Schwannomatosis (STARFISH)","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2023-08-31","conditions":"Schwannomatosis, Schwannomas, Pain, Chronic","enrollment":40},{"nctId":"NCT06347003","phase":"PHASE3","title":"Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2024-07-22","conditions":"Severe Hypertriglyceridemia","enrollment":446},{"nctId":"NCT05778188","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia","status":"RECRUITING","sponsor":"ReAlta Life Sciences, Inc.","startDate":"2023-07-27","conditions":"Hypoxic-Ischemic Encephalopathy","enrollment":42},{"nctId":"NCT06347016","phase":"PHASE3","title":"Study of Plozasiran in Adults With Severe Hypertriglyceridemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2024-07-23","conditions":"Severe Hypertriglyceridemia","enrollment":311},{"nctId":"NCT04636229","phase":"PHASE3","title":"Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Organogenesis","startDate":"2020-12-14","conditions":"Knee Osteoarthritis","enrollment":516},{"nctId":"NCT05537025","phase":"PHASE1, PHASE2","title":"Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary Fibrosis","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2023-01-30","conditions":"Idiopathic Pulmonary Fibrosis","enrollment":105},{"nctId":"NCT06347133","phase":"PHASE3","title":"Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2024-05-21","conditions":"Hypertriglyceridemia","enrollment":1456},{"nctId":"NCT04202354","phase":"PHASE1, PHASE2","title":"Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH","status":"COMPLETED","sponsor":"Arrowhead Pharmaceuticals","startDate":"2020-03-03","conditions":"Non-alcoholic Steatohepatitis","enrollment":50},{"nctId":"NCT05831111","phase":"PHASE1","title":"A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy Participants","status":"ACTIVE_NOT_RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2023-04-05","conditions":"Epstein-Barr Virus Infection","enrollment":482},{"nctId":"NCT04917861","phase":"PHASE2","title":"A Study of Zika Vaccine mRNA-1893 in Adult Participants Living in Endemic and Non-Endemic Flavivirus Areas","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2021-06-07","conditions":"Zika Virus","enrollment":808},{"nctId":"NCT06819956","phase":"PHASE3","title":"Ketorolac at Lower Doses for Analgesic Pain Control in ICU: A Pilot Feasibility Study","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-06-23","conditions":"Pain Management","enrollment":30},{"nctId":"NCT06482853","phase":"EARLY_PHASE1","title":"Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2025-01-23","conditions":"Obesity, Hypertension","enrollment":52},{"nctId":"NCT05301192","phase":"EARLY_PHASE1","title":"Angiotensin-(1-7) Cardiovascular Effects in Aging","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2022-12-09","conditions":"Aging","enrollment":26},{"nctId":"NCT03777215","phase":"EARLY_PHASE1","title":"Angiotensin-(1-7) and Energy Expenditure in Human Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amy Arnold","startDate":"2019-09-26","conditions":"Obesity","enrollment":30},{"nctId":"NCT07171723","phase":"PHASE1, PHASE2","title":"Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment","status":"RECRUITING","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2025-09-01","conditions":"Obesity &Amp; Overweight","enrollment":24},{"nctId":"NCT04537208","phase":"PHASE1, PHASE2","title":"Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and Older","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2020-09-03","conditions":"COVID-19 (Healthy Volunteers)","enrollment":441},{"nctId":"NCT04649151","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2020-12-09","conditions":"SARS-CoV-2","enrollment":4328},{"nctId":"NCT05851066","phase":"PHASE1","title":"A VSA003 Phase 1 Study in Chinese Adult Healthy Volunteers","status":"COMPLETED","sponsor":"Visirna Therapeutics HK Limited","startDate":"2023-06-01","conditions":"Dyslipidemias, Familial Hypercholesterolemia, Hypertriglyceridemia","enrollment":36},{"nctId":"NCT04798027","phase":"PHASE1, PHASE2","title":"Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2021-03-12","conditions":"COVID-19","enrollment":182},{"nctId":"NCT07169240","phase":"PHASE1","title":"Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects","status":"COMPLETED","sponsor":"ScinnoHub Pharmaceutical Co., Ltd.","startDate":"2023-02-06","conditions":"Healthy Subjects (HS)","enrollment":84},{"nctId":"NCT00532155","phase":"PHASE3","title":"A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer","status":"COMPLETED","sponsor":"Sanofi","startDate":"2007-09","conditions":"Carcinoma, Non Small Cell Lung","enrollment":913},{"nctId":"NCT07128121","phase":"PHASE2","title":"A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shenzhen Shenxin Biotechnology Co., Ltd","startDate":"2025-08-13","conditions":"Respiratory Syncytial Virus (RSV) Infection","enrollment":500},{"nctId":"NCT04824092","phase":"PHASE3","title":"Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incyte Corporation","startDate":"2021-05-11","conditions":"Diffuse Large B-cell Lymphoma","enrollment":899},{"nctId":"NCT07146087","phase":"EARLY_PHASE1","title":"Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis","status":"SUSPENDED","sponsor":"Biocells Medical","startDate":"2020-07-01","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT05127434","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2021-11-17","conditions":"Respiratory Syncytial Virus","enrollment":36814},{"nctId":"NCT04133909","phase":"PHASE3","title":"Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2019-10-30","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":806},{"nctId":"NCT05018221","phase":"PHASE3","title":"Better Evidence and Translation for Calciphylaxis","status":"RECRUITING","sponsor":"University of Sydney","startDate":"2021-08-26","conditions":"Calciphylaxis","enrollment":350},{"nctId":"NCT04658667","phase":"PHASE1","title":"HIV Vaccine in HIV-uninfected Adults","status":"COMPLETED","sponsor":"U.S. Army Medical Research and Development Command","startDate":"2022-02-03","conditions":"HIV","enrollment":81},{"nctId":"NCT04814719","phase":"","title":"Treatment and Duration Effect of Pentosan Polysulfate Sodium (PPS) in Participants With Knee Osteoarthritis Pain","status":"COMPLETED","sponsor":"Paradigm Biopharmaceuticals Ltd.","startDate":"2023-06-24","conditions":"Osteoarthritis, Knee","enrollment":133},{"nctId":"NCT05107336","phase":"PHASE1","title":"Study to Assess the Safety, Tolerability, and Pharmacokinetics (Movement of Drugs Within the Body) of AZD2693 in Healthy Participants","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-11-25","conditions":"Healthy Participants","enrollment":44},{"nctId":"NCT05995275","phase":"PHASE1, PHASE2","title":"A Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age","status":"COMPLETED","sponsor":"ModernaTX, Inc.","startDate":"2023-08-15","conditions":"Smallpox, Mpox","enrollment":351},{"nctId":"NCT07064408","phase":"NA","title":"Subanesthetic Esketamine for Hemodynamic Stability and Recovery in Elderly Thoracic Surgery Patients","status":"COMPLETED","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2023-06-01","conditions":"Hemodynamic Instability, Postoperative Recovery, Thoracic Surgery","enrollment":230},{"nctId":"NCT03384966","phase":"PHASE2","title":"A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2018-01-24","conditions":"Stable Coronary Artery Disease","enrollment":346}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":7,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Saline 0.9% (matching placebo)","genericName":"Saline 0.9% (matching placebo)","companyName":"Insel Gruppe AG, University Hospital Bern","companyId":"insel-gruppe-ag-university-hospital-bern","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Saline 0.9% is an isotonic sodium chloride solution that serves as a physiologically inert vehicle for drug delivery or fluid replacement. Used for Placebo control in clinical trials.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}